Independent
Tenure on this board
5.2 yrs
Also a director at
Ses Ai Corp (SES)
Meeting calendar
AVXL · Annual meeting · Thursday, September 24, 2026Contested
Anavex Life Sciences Corp
6 nominees · 2 ballot items · contested.
Election of six directors to the Board and ratification of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2026.
Market cap
$325M
1Y TSR
-73.3%
Board grade
C-
Record date
Jul 31, 2026
Filing
DEFC14A
Filed Aug 11, 2026 · DEFC14A
Proposals
On the ballot2
- 1
Election of Directors
ManagementBoard: FORTo elect six directors—Jiong Ma, Peter Donhauser, Gautam Patel, Axel Paeger, Adrian Senderowicz and Claus van der Velden—to the Board, each to hold office until the next annual meeting or until their successors are elected and qualified.
- 2
Ratification of Independent Registered Public Accounting Firm
ManagementBoard: FORTo ratify the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2026.
Director elections
Nominees on the ballot6
Independent
Tenure on this board
9.5 yrs
Independent
Tenure on this board
0.5 yrs
Gautam Patel, MBA
Independent
Tenure on this board
New nominee
Adrian Senderowicz, M.D.
Independent
Tenure on this board
New nominee
Independent
Tenure on this board
8.4 yrs
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | STATE STREET CORP | 4.7% | 4,383,406 | $16M |
| 2 | VANGUARD GROUP INC | 4.7% | 4,331,021 | $15M |
| 3 | BlackRock, Inc. | 4.5% | 4,149,079 | $15M |
| 4 | BlackRock, Inc. | 2.7% | 2,516,021 | $9M |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 1.9% | 1,750,590 | $6M |
| 6 | TWO SIGMA INVESTMENTS, LP | 1.8% | 1,653,696 | $6M |
| 7 | TWO SIGMA ADVISERS, LP | 1.3% | 1,209,570 | $4M |
| 8 | Summit Financial, LLC | 1.0% | 903,392 | $3M |
| 9 | NWAM LLC | 0.9% | 870,796 | $4M |
| 10 | GOLDMAN SACHS GROUP INC | 0.8% | 758,562 | $3M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Anavex Life Sciences Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Simulations Plus IncSLP
Special meeting·Aug 27, 2026·$370M
Canopy Growth CorpCGC
Annual meeting·Sep 25, 2026·$423M
Ocugen IncOCGN
Special meeting·Sep 21, 2026·$465M
Artiva Biotherapeutics IncARTV
Annual meeting·Sep 8, 2026·$576M
Replimune Group IncREPL
Annual meeting·Sep 15, 2026·$1.1B
Kestra Medical Technologies LtdKMTS
Annual meeting·Sep 9, 2026·$1.6B
Reference
Frequently asked questions
- When is the Anavex Life Sciences Corp 2026 annual meeting?
- Anavex Life Sciences Corp (AVXL) holds its 2026 annual shareholder meeting on Thursday, September 24, 2026.
- What is the record date for the Anavex Life Sciences Corp 2026 meeting?
- The record date for the Anavex Life Sciences Corp 2026 meeting is Friday, July 31, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Anavex Life Sciences Corp's 2026 meeting?
- The board is presenting 6 director nominees at the Anavex Life Sciences Corp 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Anavex Life Sciences Corp 2026 meeting?
- Shareholders will vote on 2 proposals at the Anavex Life Sciences Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.